Accessibility Menu
Beleave logo

Beleave

(OTC) BLEVF

Current Price$0.00
Market CapN/A
Since IPO (2016)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Beleave Financials at a Glance

Market Cap

N/A

Revenue (TTM)

CA$2.90M

Net Income (TTM)

-CA$15.87M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 29, 2018

BLEVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Beleave

Industry

Pharmaceuticals

Headquarters

Oakville, ON L6H 0H2, CA

BLEVF Financials

Key Financial Metrics (TTM)

Gross Margin

34.39%

Operating Margin

-989.32%

Net Income Margin

-1423.05%

Return on Equity

-341.61%

Return on Capital

-110.58%

Return on Assets

-143.10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-CA$4.94M

Operating Income

-CA$6.16M

EBITDA

-CA$7.34M

Operating Cash Flow

CA$8.77M

Capital Expenditure

-CA$3.21M

Free Cash Flow

CA$5.56M

Cash & ST Invst.

CA$120.41K

Total Debt

CA$12.37M

Beleave Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2019YOY CHG

Revenue

CA$381.94K

-52.7%

Gross Profit

-CA$908.22K

-163.6%

Gross Margin

-2.38%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$2.49M

-13.6%

EBITDA

-CA$2.14M

+14.6%

Quarterly Fundamentals

Name
Q3 2019YOY CHG

Total Cash

CA$120.41K

-93.2%

Total Debt

CA$12.37M

+61.4%

Accounts Receivable

CA$267.29K

-80.8%

Inventory

CA$2.12M

-31.7%

Long Term Debt

CA$3.12M

+37.3%

Short Term Debt

CA$9.25M

+71.6%

Return on Assets

-1.43%

N/A

Return on Invested Capital

-1.77%

N/A

Free Cash Flow

CA$551.05K

+113.1%

Operating Cash Flow

CA$517.47K

+123.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MTEMMolecular Templates, Inc.
$0.00-0.00%
ARTHArch Therapeutics, Inc.
$0.00+0.00%
MDKMMDEChem, Inc.
$0.00-100.00%
GNRSThe Greenrose Holding Company Inc.
$0.00-50.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
INTCIntel
$120.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%

Questions About BLEVF

What is the current price of Beleave?

Beleave is trading at N/A per share.

What is the 52-week range for Beleave?

Over the past 52 weeks, Beleave has traded between N/A and N/A.

How much debt does Beleave have?

Beleave total debt is unavailable.

How much cash does Beleave have on hand?

Beleave does not have cash on hand data available.

What is Beleave’s dividend yield?

Beleave does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.